tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Turkaly, 137 are a BUY (96.48%), 4 are a HOLD (2.82%), 1 are a SELL (0.7%).
Analyst David Turkaly, currently employed at JMP, carries an average stock price target met ratio of 33.69% that have a potential upside of 31.2% achieved within 218 days.
David Turkaly’s has documented 281 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LNTH, Lantheus Holdings at 14-Jan-2025.
Analyst best performing recommendations are on STIM (NEURONETICS).
The best stock recommendation documented was for STIM (NEURONETICS) at 8/14/2024. The price target of $3 was fulfilled within 167 days with a profit of $2.17 (261.45%) receiving and performance score of 15.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
4 months 21 days ago
(16-Sep-2024)
3/3 (100%)
$1.8 (21.95%)
243
Buy
$4.5
$3.06 (212.50%)
$3
1 years 5 months 26 days ago
(11-Aug-2023)
14/16 (87.5%)
$-0.55 (-10.89%)
297
Buy
$9
$7.56 (525.00%)
$6
1 years 7 months 22 days ago
(15-Jun-2023)
2/3 (66.67%)
$2.05 (29.50%)
81
Buy
$17
$15.56 (1080.56%)
$12
2 years 6 months 18 days ago
(19-Jul-2022)
0/2 (0%)
$8.43 (98.37%)
Which stock is David Turkaly is most bullish on?
Which stock is David Turkaly is most reserved on?
What Year was the first public recommendation made by David Turkaly?
